$ZNTL Zentalis Pharmaceuticals, Inc. Insider Trading Week 49/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Zentalis Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Zentalis Pharmaceuticals, Inc. in week 49/2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Gallagher Cam | Director | Sell | S | 57.93 | 1,118 | 64,771 | 580,192 | 581.3 K to 580.2 K (-0.19 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Gallagher Cam | Director | Sell | S | 57.93 | 1,118 | 64,771 | 580,192 | 581.3 K to 580.2 K (-0.19 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Gallagher Cam | Director | Sell | S | 57.54 | 13,044 | 750,616 | 581,310 | 594.4 K to 581.3 K (-2.19 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Gallagher Cam | Director | Sell | S | 57.54 | 13,044 | 750,616 | 581,310 | 594.4 K to 581.3 K (-2.19 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Gallagher Cam | Director | Sell | S | 56.08 | 2,226 | 124,836 | 594,354 | 596.6 K to 594.4 K (-0.37 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Gallagher Cam | Director | Sell | S | 56.08 | 2,226 | 124,836 | 594,354 | 596.6 K to 594.4 K (-0.37 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Gallagher Cam | Director | Sell | S | 55.37 | 4,800 | 265,781 | 596,580 | 601.4 K to 596.6 K (-0.80 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Gallagher Cam | Director | Sell | S | 55.37 | 4,800 | 265,781 | 596,580 | 601.4 K to 596.6 K (-0.80 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Gallagher Cam | Director | Sell | S | 54.19 | 1,385 | 75,052 | 601,380 | 602.8 K to 601.4 K (-0.23 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Gallagher Cam | Director | Sell | S | 54.19 | 1,385 | 75,052 | 601,380 | 602.8 K to 601.4 K (-0.23 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Gallagher Cam | Director | Sell | S | 54.39 | 405 | 22,026 | 602,765 | 603.2 K to 602.8 K (-0.07 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Gallagher Cam | Director | Sell | S | 54.39 | 405 | 22,026 | 602,765 | 603.2 K to 602.8 K (-0.07 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Gallagher Cam | Director | Sell | S | 53.71 | 5,158 | 277,042 | 603,170 | 608.3 K to 603.2 K (-0.85 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Gallagher Cam | Director | Sell | S | 53.71 | 5,158 | 277,042 | 603,170 | 608.3 K to 603.2 K (-0.85 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Gallagher Cam | Director | Sell | S | 52.53 | 1,006 | 52,844 | 608,328 | 609.3 K to 608.3 K (-0.17 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Gallagher Cam | Director | Sell | S | 52.53 | 1,006 | 52,844 | 608,328 | 609.3 K to 608.3 K (-0.17 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Gallagher Cam | Director | Sell | S | 50.84 | 123 | 6,253 | 609,334 | 609.5 K to 609.3 K (-0.02 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Gallagher Cam | Director | Sell | S | 50.84 | 123 | 6,253 | 609,334 | 609.5 K to 609.3 K (-0.02 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Gallagher Cam | Director | Sell | S | 51.17 | 4,014 | 205,408 | 609,457 | 613.5 K to 609.5 K (-0.65 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Gallagher Cam | Director | Sell | S | 51.17 | 4,014 | 205,408 | 609,457 | 613.5 K to 609.5 K (-0.65 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Gallagher Cam | Director | Sell | S | 50.76 | 3,460 | 175,639 | 613,471 | 616.9 K to 613.5 K (-0.56 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Gallagher Cam | Director | Sell | S | 50.76 | 3,460 | 175,639 | 613,471 | 616.9 K to 613.5 K (-0.56 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 54.39 | 391 | 21,265 | 277,679 | 278.1 K to 277.7 K (-0.14 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 54.39 | 391 | 21,265 | 277,679 | 278.1 K to 277.7 K (-0.14 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 53.71 | 4,983 | 267,642 | 278,070 | 283.1 K to 278.1 K (-1.76 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 53.71 | 4,983 | 267,642 | 278,070 | 283.1 K to 278.1 K (-1.76 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 52.53 | 971 | 51,006 | 283,053 | 284 K to 283.1 K (-0.34 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 52.53 | 971 | 51,006 | 283,053 | 284 K to 283.1 K (-0.34 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 50.84 | 119 | 6,050 | 284,024 | 284.1 K to 284 K (-0.04 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 50.84 | 119 | 6,050 | 284,024 | 284.1 K to 284 K (-0.04 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 51.17 | 3,877 | 198,397 | 284,143 | 288 K to 284.1 K (-1.35 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 51.17 | 3,877 | 198,397 | 284,143 | 288 K to 284.1 K (-1.35 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 50.76 | 3,343 | 169,700 | 288,020 | 291.4 K to 288 K (-1.15 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 50.76 | 3,343 | 169,700 | 288,020 | 291.4 K to 288 K (-1.15 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Bunker Kevin D. | Chief Operating Off ... | Sell | S | 54.39 | 659 | 35,841 | 1,053,880 | 1.1 M to 1.1 M (-0.06 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Bunker Kevin D. | Chief Operating Off ... | Sell | S | 54.39 | 659 | 35,841 | 1,053,880 | 1.1 M to 1.1 M (-0.06 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Bunker Kevin D. | Chief Operating Off ... | Sell | S | 53.71 | 8,395 | 450,905 | 1,054,539 | 1.1 M to 1.1 M (-0.79 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Bunker Kevin D. | Chief Operating Off ... | Sell | S | 53.71 | 8,395 | 450,905 | 1,054,539 | 1.1 M to 1.1 M (-0.79 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Bunker Kevin D. | Chief Operating Off ... | Sell | S | 52.53 | 1,637 | 85,990 | 1,062,934 | 1.1 M to 1.1 M (-0.15 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Bunker Kevin D. | Chief Operating Off ... | Sell | S | 52.53 | 1,637 | 85,990 | 1,062,934 | 1.1 M to 1.1 M (-0.15 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Bunker Kevin D. | Chief Operating Off ... | Sell | S | 50.84 | 201 | 10,219 | 1,064,571 | 1.1 M to 1.1 M (-0.02 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Bunker Kevin D. | Chief Operating Off ... | Sell | S | 50.84 | 201 | 10,219 | 1,064,571 | 1.1 M to 1.1 M (-0.02 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Bunker Kevin D. | Chief Operating Off ... | Sell | S | 51.17 | 6,533 | 334,312 | 1,064,772 | 1.1 M to 1.1 M (-0.61 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Bunker Kevin D. | Chief Operating Off ... | Sell | S | 51.17 | 6,533 | 334,312 | 1,064,772 | 1.1 M to 1.1 M (-0.61 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Bunker Kevin D. | Chief Operating Off ... | Sell | S | 50.76 | 5,632 | 285,896 | 1,071,305 | 1.1 M to 1.1 M (-0.52 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | Bunker Kevin D. | Chief Operating Off ... | Sell | S | 50.76 | 5,632 | 285,896 | 1,071,305 | 1.1 M to 1.1 M (-0.52 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | SUN ANTHONY Y | President & CEO | Sell | S | 54.39 | 2,153 | 117,094 | 2,017,605 | 2 M to 2 M (-0.11 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | SUN ANTHONY Y | President & CEO | Sell | S | 54.39 | 2,153 | 117,094 | 2,017,605 | 2 M to 2 M (-0.11 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | SUN ANTHONY Y | President & CEO | Sell | S | 53.71 | 27,446 | 1,474,155 | 2,019,758 | 2 M to 2 M (-1.34 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | SUN ANTHONY Y | President & CEO | Sell | S | 53.71 | 27,446 | 1,474,155 | 2,019,758 | 2 M to 2 M (-1.34 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | SUN ANTHONY Y | President & CEO | Sell | S | 52.53 | 5,350 | 281,032 | 2,047,204 | 2.1 M to 2 M (-0.26 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | SUN ANTHONY Y | President & CEO | Sell | S | 52.53 | 5,350 | 281,032 | 2,047,204 | 2.1 M to 2 M (-0.26 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | SUN ANTHONY Y | President & CEO | Sell | S | 50.84 | 657 | 33,401 | 2,052,554 | 2.1 M to 2.1 M (-0.03 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | SUN ANTHONY Y | President & CEO | Sell | S | 50.84 | 657 | 33,401 | 2,052,554 | 2.1 M to 2.1 M (-0.03 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | SUN ANTHONY Y | President & CEO | Sell | S | 51.17 | 21,356 | 1,092,846 | 2,053,211 | 2.1 M to 2.1 M (-1.03 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | SUN ANTHONY Y | President & CEO | Sell | S | 51.17 | 21,356 | 1,092,846 | 2,053,211 | 2.1 M to 2.1 M (-1.03 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | SUN ANTHONY Y | President & CEO | Sell | S | 50.76 | 18,413 | 934,694 | 2,074,567 | 2.1 M to 2.1 M (-0.88 %) |
| Dec 08 2020 | ZNTL | Zentalis Pharmaceu ... | SUN ANTHONY Y | President & CEO | Sell | S | 50.76 | 18,413 | 934,694 | 2,074,567 | 2.1 M to 2.1 M (-0.88 %) |